Trial · NCT02143414
Results by group381
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 381
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Overall Survival Rate (Cohort I) | Cohort I (Ph-) | 34 | 95% Confidence Interval 18 to 54 | percentage of participants | |
| Incidence of Dose-limiting Toxicity (Cohort II) | Cohort II (Ph+/Ph-like) | 0 | Participants | ||
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Induction: Cohort I (Ph-) | Abdominal pain | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Induction: Cohort II (Ph+/Ph-like) | Abdominal pain | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Post-remission: Cohort I (Ph-) | Abdominal pain | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Post-remission: Cohort II (Ph+/Ph-like) | Abdominal pain | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Maintenance: Cohort I (Ph-) | Abdominal pain | 1 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Maintenance: Cohort II (Ph+/Ph-like) | Abdominal pain | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Induction: Cohort I (Ph-) | Adult respiratory distress syndrome | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Induction: Cohort II (Ph+/Ph-like) | Adult respiratory distress syndrome | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Post-remission: Cohort I (Ph-) | Adult respiratory distress syndrome | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Post-remission: Cohort II (Ph+/Ph-like) | Adult respiratory distress syndrome | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Maintenance: Cohort I (Ph-) | Adult respiratory distress syndrome | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Maintenance: Cohort II (Ph+/Ph-like) | Adult respiratory distress syndrome | 1 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Induction: Cohort I (Ph-) | Agitation | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Induction: Cohort II (Ph+/Ph-like) | Agitation | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Post-remission: Cohort I (Ph-) | Agitation | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Post-remission: Cohort II (Ph+/Ph-like) | Agitation | 1 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Maintenance: Cohort I (Ph-) | Agitation | 0 | Participants | |
| Number of Participants With Grade 3 Through 5 Adverse Events That Are Related to Study Drugs | Maintenance: Cohort II (Ph+/Ph-like) | Agitation | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02143414/results